These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30859414)

  • 21. New hypothesis and treatment targets of depression: an integrated view of key findings.
    Cai S; Huang S; Hao W
    Neurosci Bull; 2015 Feb; 31(1):61-74. PubMed ID: 25575479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of mTOR in depression and antidepressant responses.
    Abelaira HM; Réus GZ; Neotti MV; Quevedo J
    Life Sci; 2014 Apr; 101(1-2):10-4. PubMed ID: 24582593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurophysiologic Advance in Depressive Disorder.
    Xu L; Mao R
    Adv Exp Med Biol; 2019; 1180():99-116. PubMed ID: 31784959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The promise of ketamine for treatment-resistant depression: current evidence and future directions.
    DeWilde KE; Levitch CF; Murrough JW; Mathew SJ; Iosifescu DV
    Ann N Y Acad Sci; 2015 May; 1345(1):47-58. PubMed ID: 25649308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of circadian properties of temporal processing with rapid antidepressant response to wake and light therapy in bipolar disorder.
    Yoshiike T; Dallaspezia S; Kuriyama K; Yamada N; Colombo C; Benedetti F
    J Affect Disord; 2020 Feb; 263():72-79. PubMed ID: 31818799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regionally selective activation and differential regulation of ERK, JNK and p38 MAP kinase signalling pathway by protein kinase C in mood modulation.
    Galeotti N; Ghelardini C
    Int J Neuropsychopharmacol; 2012 Jul; 15(6):781-93. PubMed ID: 21682943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine.
    Chaki S; Fukumoto K
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
    Park M; Newman LE; Gold PW; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
    J Psychiatr Res; 2017 Jan; 84():113-118. PubMed ID: 27718369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of eEF2 kinase in the rapid antidepressant actions of ketamine.
    Suzuki K; Monteggia LM
    Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 7T
    Evans JW; Lally N; An L; Li N; Nugent AC; Banerjee D; Snider SL; Shen J; Roiser JP; Zarate CA
    Neuropsychopharmacology; 2018 Aug; 43(9):1908-1914. PubMed ID: 29748628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variation in the calcium/calmodulin-dependent protein kinase (CaMK) pathway is associated with antidepressant response in females.
    Shi Y; Yuan Y; Xu Z; Pu M; Wang C; Zhang Y; Liu Z; Wang C; Li L; Zhang Z
    J Affect Disord; 2012 Feb; 136(3):558-66. PubMed ID: 22119081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constitutive activation of the ERK-MAPK pathway in the suprachiasmatic nuclei inhibits circadian resetting.
    Hainich EC; Pizzio GA; Golombek DA
    FEBS Lett; 2006 Dec; 580(28-29):6665-8. PubMed ID: 17125769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
    Koike H; Iijima M; Chaki S
    Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel therapeutic strategies in major depression: focus on RNAi and ketamine.
    Bortolozzi A; Celada P; Artigas F
    Curr Pharm Des; 2014; 20(23):3848-60. PubMed ID: 24180396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic use of sleep deprivation in depression.
    Giedke H; Schwärzler F
    Sleep Med Rev; 2002 Oct; 6(5):361-77. PubMed ID: 12531127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of Activation of Mitogen-Activated Protein Kinase (MAPK)/Extracellular Signal-Regulated Kinase (ERK) Signaling Pathway in Proliferation of Urethral Plate Fibroblasts in Finasteride-Induced Rat Hypospadias.
    An N; Peng J; He G; Fan X; Li F; Chen H
    Med Sci Monit; 2018 Dec; 24():8984-8992. PubMed ID: 30538214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-photic phase shifting of the circadian clock: role of the extracellular signal-responsive kinases I/II/mitogen-activated protein kinase pathway.
    Antle MC; Tse F; Koke SJ; Sterniczuk R; Hagel K
    Eur J Neurosci; 2008 Dec; 28(12):2511-8. PubMed ID: 19087176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal regulation of light-induced extracellular signal-regulated kinase activation in the suprachiasmatic nucleus.
    Butcher GQ; Lee B; Obrietan K
    J Neurophysiol; 2003 Dec; 90(6):3854-63. PubMed ID: 12930817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disinhibition of the extracellular-signal-regulated kinase restores the amplification of circadian rhythms by lithium in cells from bipolar disorder patients.
    McCarthy MJ; Wei H; Landgraf D; Le Roux MJ; Welsh DK
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1310-9. PubMed ID: 27216486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.
    Guan J; Chen XP; Zhu H; Luo SF; Cao B; Ding L
    World J Gastroenterol; 2004 Dec; 10(23):3522-7. PubMed ID: 15526378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.